Experience

Davis Polk advised the sales agent on the SEC-registered at-the-market offering by IDEAYA Biosciences, Inc. of its common stock for up to an aggregate amount of $50 million. Based in…

Davis Polk advised the representatives of the underwriters in connection with an initial public offering of Inventiva S.A.’s 7,478,261 American Depositary Shares. Aggregate gross…

Davis Polk advised the underwriters in connection with a public offering of 6,666,667 shares of common stock of IDEAYA Biosciences, Inc. at $15.00 per share, for total gross proceeds of …

Davis Polk advised Shockwave Medical, Inc. on its SEC-registered public offering of 1,955,000 shares of common stock for an aggregate price to the public of approximately $89.4 million,…

Davis Polk advised the joint book-running managers in connection with a $10 billion SEC-registered debt offering by Amazon.com, Inc., consisting of $1 billion of its 0.400% notes due…

Davis Polk advised the sole bookrunner in connection with the SEC-registered offering of 2,500,000 shares of Class A common stock of Appian Corporation by Appian and certain existing…

Davis Polk is advising SS&C Technologies Holdings, Inc. on its $120 million acquisition of Innovest Systems, LLC. The transaction is expected to close in the second quarter of 2020. SS…

Davis Polk advised the representatives of the several underwriters in connection with the registered offering by DXC Technology Company of $500 million aggregate principal amount of 4.000%…

Davis Polk advised the underwriters in connection with an SEC-registered offering by Citrix Systems, Inc. of $750 million aggregate principal amount of its 3.300% senior notes due 2030…

Davis Polk advised Shockwave Medical, Inc. on its SEC-registered public offering of 2,481,781 shares of common stock for an aggregate price to the public of approximately $90 million. The…